Skip to content

Noel A. Armenakas, MD

NPI 1043260219ActiveIndividual· Urology· New York, NY

Urology (MD) in New York, New York, licensed in NY, with an NPI issued in May 2006. Their prescriptions cost Medicare Part D more than their services did: $331,676 for 1,441 claims, against $126,136 paid for services in 2024. Merck Sharp & Dohme LLC reported $750.00 in payments in 2025, mostly consulting fees.

Overview

NPI1043260219
StatusActive
Entity typeIndividual
CredentialMD
Sole proprietorYes
NPI issuedMay 11, 2006
Last updated in NPPESNov 9, 2016

Specialties and licenses

TaxonomyCodeLicenseState
Urology Primary208800000X177999NY

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Oct 9, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 10, 2026No match—
New York OMIG · Nov 10, 2026No match—
Ohio Medicaid · Nov 10, 2026No match—
Pennsylvania Medicheck · Nov 10, 2026No match—
Washington HCA · Nov 10, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Practitioner - Urology (NY)
Accepts assignmentYes (participating)

Medicare services in 2024

Medicare patients518
Services billed1,567 across 39 procedure codes
Paid by Medicare$126,136

Part D prescriptions in 2024

Prescriptions (claims)1,441 · 3,777 30-day fills
Patients372
Total drug cost$331,676
Generic share94% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$750.00 · 1 payment from 1 company
  • 2024$1,543 · 2 payments from 2 companies

Top paying companies in 2025

CompanyAmountPayments
Merck Sharp & Dohme LLC$750.001

What the 2025 payments were for

  • Consulting Fee$750.00 · 1 payment

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Urology providers in New York

All Urology providers in New York →